OrthoLogic expands Chrysalin rights to soft tissue
This article was originally published in Clinica
Executive Summary
OrthoLogic is to gain rights to Chrysalis BioTechnology's Chrysalin tissue repair product for soft tissue applications, including cartilage, tendon and ligament repair, for a one-off payment of $1 million. OrthoLogic already has a worldwide licence to the product for hard tissue indications, including fracture and spinal repair.